• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胶质母细胞瘤的再次手术

Reoperation for glioblastoma.

作者信息

Young B, Oldfield E H, Markesbery W R, Haack D, Tibbs P A, McCombs P, Chin H W, Maruyama Y, Meacham W F

出版信息

J Neurosurg. 1981 Dec;55(6):917-21. doi: 10.3171/jns.1981.55.6.0917.

DOI:10.3171/jns.1981.55.6.0917
PMID:6271933
Abstract

The results of a second operation for tumor removal in 24 adult patients with supratentorial glioblastoma multiforme or anaplastic astrocytoma were analyzed. The median survival time after reoperation was 14 weeks. Five of the 24 patients lived 6 months or longer after reoperation. Only three of these patients maintained a Karnofsky rating (KR) of at least 60 for 6 months or longer after reoperation. Preoperative neurological status (KR) is the most significant determinant of survival after reoperation (p = 0.02). When the KR is at least 60, median survival after reoperation is 22 weeks. When the KR prior to reoperation is less than 60, median survival is 9 weeks. Only one of 13 patients with a KR of less than 60 prior to reoperation survived longer than 6 months after the second operation. The interval between first and second operation is significantly related to survival (p = 0.03), but when adjustment is made for the KR the interoperative interval is no longer significantly related to survival after the second operation (p = 0.39). Age, sex, and location of tumor were not significantly related to duration of survival. This study suggests that reoperation is most likely to produce the best result when the KR is at least 60 and the interval between operations is longer than 6 months. Using these criteria, one-third of the patients could be expected to survive with a KR of at least 60 for 6 months. The study indicates that reoperation should not be carried out when the KR is less than 60.

摘要

对24例患有幕上多形性胶质母细胞瘤或间变性星形细胞瘤的成年患者进行肿瘤切除二次手术的结果进行了分析。二次手术后的中位生存时间为14周。24例患者中有5例在二次手术后存活了6个月或更长时间。这些患者中只有3例在二次手术后6个月或更长时间内卡氏评分(KR)维持在至少60分。术前神经状态(KR)是二次手术后生存的最重要决定因素(p = 0.02)。当KR至少为60时,二次手术后的中位生存时间为22周。当二次手术前KR小于60时,中位生存时间为9周。二次手术前KR小于60的13例患者中只有1例在第二次手术后存活超过6个月。第一次和第二次手术之间的间隔与生存显著相关(p = 0.03),但在对KR进行调整后,手术间隔与第二次手术后的生存不再显著相关(p = 0.39)。年龄、性别和肿瘤位置与生存时间无显著相关性。本研究表明,当KR至少为60且手术间隔超过6个月时,二次手术最有可能产生最佳结果。使用这些标准,预计三分之一的患者在KR至少为60的情况下能存活6个月。该研究表明,当KR小于60时不应进行二次手术。

相似文献

1
Reoperation for glioblastoma.胶质母细胞瘤的再次手术
J Neurosurg. 1981 Dec;55(6):917-21. doi: 10.3171/jns.1981.55.6.0917.
2
Radical surgery and reoperation in supratentorial malignant glial tumors.幕上恶性胶质瘤的根治性手术及再次手术
Minim Invasive Neurosurg. 1998 Dec;41(4):209-13. doi: 10.1055/s-2008-1052044.
3
Reoperation for recurrent glioblastoma and anaplastic astrocytoma.复发性胶质母细胞瘤和间变性星形细胞瘤的再次手术
Neurosurgery. 1987 Nov;21(5):615-21. doi: 10.1227/00006123-198711000-00002.
4
Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas.手术切除范围对幕上胶质母细胞瘤和间变性星形细胞瘤患者生存及生活质量的影响。
Neurosurgery. 1987 Aug;21(2):201-6. doi: 10.1227/00006123-198708000-00012.
5
The value of reoperation for recurrent glioblastoma.复发性胶质母细胞瘤再次手术的价值。
Can J Surg. 1993 Jun;36(3):271-5.
6
[Clinical analysis of the fatal cases of adult malignant gliomas after aggressive treatment].[积极治疗后成人恶性胶质瘤致死病例的临床分析]
No Shinkei Geka. 1994 Mar;22(3):207-13.
7
Reoperation in the treatment of recurrent intracranial malignant gliomas.再次手术治疗复发性颅内恶性胶质瘤。
Neurosurgery. 1987 Nov;21(5):607-14. doi: 10.1227/00006123-198711000-00001.
8
Experiences with reoperation on recurrent glioblastoma multiforme.复发性多形性胶质母细胞瘤再次手术的经验。
Zentralbl Neurochir. 2001;62(2):43-7. doi: 10.1055/s-2002-19477.
9
[Supratentorial glioma: analysis of clinical and temporal parameters in 163 cases].[幕上胶质瘤:163例临床及时间参数分析]
Neurochirurgia (Stuttg). 1993 Nov;36(6):189-93. doi: 10.1055/s-2008-1053826.
10
Residual tumor volume and patient survival following reoperation for recurrent glioblastoma.复发性胶质母细胞瘤再次手术后的残余肿瘤体积与患者生存。
J Neurosurg. 2014 Oct;121(4):802-9. doi: 10.3171/2014.6.JNS132038. Epub 2014 Jul 25.

引用本文的文献

1
The impact of intraoperative mapping during re-resection in recurrent gliomas: a systematic review.复发性胶质瘤再次切除术中术中定位的影响:一项系统评价
J Neurooncol. 2025 Feb;171(3):485-493. doi: 10.1007/s11060-024-04874-1. Epub 2024 Nov 18.
2
Targeting Subventricular Zone Progenitor Cells with Intraventricular Liposomal Encapsulated Cytarabine in Patients with Secondary Glioblastoma : A Report of Two Cases.采用脑室内脂质体包裹阿糖胞苷靶向治疗继发性胶质母细胞瘤患者的脑室下区祖细胞:两例报告
SN Compr Clin Med. 2020 Jun;2(6):836-843. doi: 10.1007/s42399-020-00322-z. Epub 2020 May 23.
3
Histopathologic quantification of viable tumor versus treatment effect in surgically resected recurrent glioblastoma.
手术切除复发性胶质母细胞瘤中存活肿瘤与治疗效果的组织病理学定量。
J Neurooncol. 2019 Jan;141(2):421-429. doi: 10.1007/s11060-018-03050-6. Epub 2018 Nov 16.
4
Outcomes after second surgery for recurrent glioblastoma: a retrospective case-control study.复发性胶质母细胞瘤二次手术后的结果:一项回顾性病例对照研究。
J Neurooncol. 2018 Apr;137(2):409-415. doi: 10.1007/s11060-017-2731-2. Epub 2018 Jan 2.
5
Management and treatment recommendations for World Health Organization Grade III and IV gliomas.世界卫生组织III级和IV级胶质瘤的管理与治疗建议
Int J Health Sci (Qassim). 2017 Jul-Sep;11(3):54-62.
6
Indications and Efficacy of Gamma Knife Stereotactic Radiosurgery for Recurrent Glioblastoma: 2 Decades of Institutional Experience.伽玛刀立体定向放射外科治疗复发性胶质母细胞瘤的适应症和疗效:二十年的机构经验
Neurosurgery. 2017 Jan 1;80(1):129-139. doi: 10.1227/NEU.0000000000001344.
7
The evolving roles and controversies of radiotherapy in the treatment of glioblastoma.放射治疗在胶质母细胞瘤治疗中不断演变的作用及争议
J Med Radiat Sci. 2016 Jun;63(2):114-23. doi: 10.1002/jmrs.149. Epub 2016 Jan 21.
8
Clinical benefit from resection of recurrent glioblastomas: results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection.复发性胶质母细胞瘤切除的临床获益:一项多中心研究结果,该研究纳入了503例接受手术切除的复发性胶质母细胞瘤患者。
Neuro Oncol. 2016 Jan;18(1):96-104. doi: 10.1093/neuonc/nov145. Epub 2015 Aug 4.
9
The role of cytoreductive surgery in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.细胞减积手术在进展性胶质母细胞瘤治疗中的作用:系统评价和循证临床实践指南。
J Neurooncol. 2014 Jul;118(3):479-88. doi: 10.1007/s11060-013-1336-7. Epub 2014 Apr 23.
10
Hypofractionated stereotactic radiation therapy for recurrent glioblastoma: single institutional experience.复发性胶质母细胞瘤的分次立体定向放射治疗:单机构经验。
Radiat Oncol. 2013 Sep 25;8:222. doi: 10.1186/1748-717X-8-222.